IGF1R (phospho Tyr1131 / Tyr11
35 / Tyr1136) / Insulin Receptor (phospho Tyr1146 / Tyr1150 / Tyr1151) antibody- ￥5300
- GeneTex
- 美国
- GTX25681
- 2025年07月14日
- WB, IHC-Fr
- Rabbit
- Human, Mouse, Rat, Chicken
企业认证
相关产品推荐更多 >
![BAG3 antibody [N1C1]](https://img1.dxycdn.com/2023/0711/255/2344116916935858761-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Synthetic phosphopeptide derived from the region of IR/IGF1R that contains tyrosines 1146, 1150 and 1151 of the human insulin receptor. The corresponding residues in the IGF1R are 1131, 1135 and 1136.
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4℃. For long-term storage, aliquot and store at -20℃ or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Mouse, Rat, Chicken
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX25681
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Rabbit
- 应用范围：
WB, IHC-Fr
- 浓度：
Batch dependent (Please refer to the vial label for the specific concentration.)
- 靶点：
IGF1R (phospho Tyr1131 / Tyr1135 / Tyr1136) / Insulin Receptor (phospho Tyr1146 / Tyr1150 / Tyr1151)
- 抗体英文名：
IGF1R (phospho Tyr1131 / Tyr1135 / Tyr1136) / Insulin Receptor (phospho Tyr1146 / Tyr1150 / Tyr1151) antibody
- 抗体名：
IGF1R (phospho Tyr1131 / Tyr1135 / Tyr1136) / Insulin Receptor (phospho Tyr1146 / Tyr1150 / Tyr1151) 抗体
- 规格：
50 μl
WB analysis of samples using GTX25681 IGF1R (phospho Tyr1131 / Tyr1135 / Tyr1136) / Insulin Receptor (phospho Tyr1146 / Tyr1150 / Tyr1151) antibody. The data show that only the immunogen phosphopeptide blocks the signal, demonstrating the specificity of the antibody.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Tramutola A et al., Neurobiol Dis 2020 (PMID:31987911)
Chen YT et al., Oncotarget 2016 (PMID:27322146)
Basso D et al., J Cell Physiol 2011 (PMID:20717964)
Zuliani I et al., Neurotherapeutics 2020 (PMID:33258073)
技术资料暂无技术资料 索取技术资料
